VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $826,000 | -2.7% | 285,319 | +125.3% | 0.00% | – |
| Q3 2021 | $849,000 | -5.2% | 126,642 | -11.9% | 0.00% | – |
| Q2 2021 | $896,000 | +52.6% | 143,707 | +50.5% | 0.00% | – |
| Q1 2021 | $587,000 | -34.0% | 95,504 | -27.9% | 0.00% | -100.0% |
| Q4 2020 | $889,000 | +20.3% | 132,496 | +5.2% | 0.00% | 0.0% |
| Q3 2020 | $739,000 | -24.2% | 125,947 | -11.1% | 0.00% | 0.0% |
| Q2 2020 | $975,000 | +69.6% | 141,690 | +10.6% | 0.00% | 0.0% |
| Q1 2020 | $575,000 | -84.2% | 128,053 | -71.8% | 0.00% | -50.0% |
| Q4 2019 | $3,642,000 | +326.5% | 454,140 | +266.0% | 0.00% | – |
| Q3 2019 | $854,000 | -15.3% | 124,095 | +2.2% | 0.00% | – |
| Q2 2019 | $1,008,000 | -6.5% | 121,407 | +11.9% | 0.00% | -100.0% |
| Q1 2019 | $1,078,000 | +69.5% | 108,539 | +30.9% | 0.00% | – |
| Q4 2018 | $636,000 | -17.5% | 82,939 | +87.5% | 0.00% | -100.0% |
| Q3 2018 | $771,000 | +32.9% | 44,243 | -27.6% | 0.00% | – |
| Q2 2018 | $580,000 | – | 61,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
| Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
| Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
| Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
| Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
| DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
| 5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
| Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |